Crinetics Pharmaceuticals
CRNX
CRNX
140 hedge funds and large institutions have $974M invested in Crinetics Pharmaceuticals in 2023 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 56 increasing their positions, 33 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
140
Holders Change
+12
Holders Change %
+9.38%
% of All Funds
2.21%
Holding in Top 10
6
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.09%
New
27
Increased
56
Reduced
33
Closed
15
Calls
$32K
Puts
$446K
Net Calls
-$414K
Net Calls Change
-$884K
Top Buyers
| 1 |
1
T. Rowe Price Associates
Baltimore,
Maryland
|
$25.8M |
| 2 |
2
BlackRock
New York
|
$82.9M |
| 3 |
IC
3
Ikarian Capital
Dallas,
Texas
|
$8.56M |
| 4 |
4
Jennison Associates
New York
|
$8.32M |
| 5 |
PBA
5
Paradigm Biocapital Advisors
New York
|
$25.1M |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
TWA
151
TCI Wealth Advisors
Tucson,
Arizona
| – | -$3.08K | -192 | Closed |
|
152
Northwestern Mutual Wealth Management
Milwaukee,
Wisconsin
| – | -$2.25K | -140 | Closed |
|
|
AF
153
Allworth Financial
Folsom,
California
| – | -$1.61K | -100 | Closed |
|
|
NA
154
NewEdge Advisors
New Orleans,
Louisiana
| – | -$964 | -60 | Closed |
|
|
VFA
155
Values First Advisors
Gray,
Tennessee
| – | -$7 | – | – |
|